Genome & Company Statistics

Total Valuation

KOSDAQ:314130 has a market cap or net worth of KRW 73.05 billion. The enterprise value is 75.78 billion.

Market Cap	73.05B
Enterprise Value	75.78B

Important Dates

The last earnings date was Friday, March 21, 2025.

Earnings Date	Mar 21, 2025
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:314130 has 31.09 million shares outstanding. The number of shares has increased by 7.86% in one year.

Current Share Class	n/a
Shares Outstanding	31.09M
Shares Change (YoY)	+7.86%
Shares Change (QoQ)	+174.75%
Owned by Insiders (%)	21.39%
Owned by Institutions (%)	0.69%
Float	18.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.58
PB Ratio	3.33
P/TBV Ratio	2.92
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.77
EV / Sales	2.73
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.73

Financial Position

The company has a current ratio of 3.08, with a Debt / Equity ratio of 0.32.

Current Ratio	3.08
Quick Ratio	2.80
Debt / Equity	0.32
Debt / EBITDA	n/a
Debt / FCF	-1.58
Interest Coverage	-6.83

Financial Efficiency

Return on equity (ROE) is -25.26% and return on invested capital (ROIC) is -11.16%.

Return on Equity (ROE)	-25.26%
Return on Assets (ROA)	-9.78%
Return on Invested Capital (ROIC)	-11.16%
Return on Capital Employed (ROCE)	-20.59%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	100
Asset Turnover	0.18
Inventory Turnover	2.59

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -50.38% in the last 52 weeks. The beta is 1.07, so KOSDAQ:314130's price volatility has been similar to the market average.

Beta (5Y)	1.07
52-Week Price Change	-50.38%
50-Day Moving Average	2,660.70
200-Day Moving Average	3,567.95
Relative Strength Index (RSI)	31.96
Average Volume (20 Days)	105,204

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:314130 had revenue of KRW 27.74 billion and -20.11 billion in losses. Loss per share was -660.00.

Revenue	27.74B
Gross Profit	15.67B
Operating Income	-24.20B
Pretax Income	-28.21B
Net Income	-20.11B
EBITDA	-16.75B
EBIT	-24.20B
Loss Per Share	-660.00

Full Income Statement

Balance Sheet

The company has 80.93 billion in cash and 32.02 billion in debt, giving a net cash position of 48.91 billion or 1,573.28 per share.

Cash & Cash Equivalents	80.93B
Total Debt	32.02B
Net Cash	48.91B
Net Cash Per Share	1,573.28
Equity (Book Value)	99.06B
Book Value Per Share	705.39
Working Capital	62.12B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -16.33 billion and capital expenditures -3.97 billion, giving a free cash flow of -20.30 billion.

Operating Cash Flow	-16.33B
Capital Expenditures	-3.97B
Free Cash Flow	-20.30B
FCF Per Share	-653.06

Full Cash Flow Statement

Margins

Gross margin is 56.48%, with operating and profit margins of -87.22% and -72.49%.

Gross Margin	56.48%
Operating Margin	-87.22%
Pretax Margin	-101.69%
Profit Margin	-72.49%
EBITDA Margin	-60.38%
EBIT Margin	-87.22%
FCF Margin	n/a

Dividends & Yields

KOSDAQ:314130 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.86%
Shareholder Yield	-7.86%
Earnings Yield	-27.53%
FCF Yield	-27.79%

Stock Splits

The last stock split was on August 6, 2024. It was a forward split with a ratio of 2.

Last Split Date	Aug 6, 2024
Split Type	Forward
Split Ratio	2

Scores

KOSDAQ:314130 has an Altman Z-Score of -1.15. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.15
Piotroski F-Score	n/a